Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival

Surgery Today

Volumn 29, Issue 11, 1999, Pages 1141-1147

  Yokoyama, Hideki ^a   Ishida, Teruyoshi ^a   Sugio, Kenji ^a   Inoue, Takashi ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Lung cancer; Multidrug resistance; P glycoprotein; Postoperative chemotherapy

Indexed keywords

GLYCOPROTEIN P; MONOCLONAL ANTIBODY C 219; UNCLASSIFIED DRUG;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

EID: 0032756995     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02482262     Document Type: Article

References (32)

1. 1. Ministry of Health and Welfare (1995) Vital statistics of Japan 1993, vol. 3. Ministry of Health and Welfare, Japan
2. 2. Ishida T, Yokoyama H, Kaneko S, Sugio K, Sugimachi K (1990) Long-term results of operation for non-small cell lung cancer in the elderly. Ann Thorac Surg 50:919-922
3. 3. Ishida T, Yano T, Maeda K, Kaneko K, Tateishi M, Sugimachi K (1990) Strategy for lymphadenectomy in lung cancer; three centimeters or less in diameter. Ann Thorac Surg 50:708-713
4. 4. Tsubota N, Yoshimura M (1996) Skip metastasis and hidden N2 disease in lung cancer: how successful is mediastinal dissection? Surg Today 26:169-172
5. 5. Mountain C (1986) A new international staging system for lung cancer. Chest 89(Suppl.):225s-233s
6. 6. Homes EC, Hill LD, Gail M (1985) A randomized comparison of the effect of adjuvant therapy on resected stage II and stage III non-small cell carcinoma of the lung. The Lung Cancer Study Group. Ann Surg 202:335-341
7. 7. Shields TW, Hoggins GA, Humphrey EW, Matthews MJ, Keehn RJ (1982) Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung. Cancer 50:1713-1721
8. 8. Hara N, Ohta M, Ichinose Y, Motohiro A, Ishida T, Noge S, Miyake J (1985) Surgical adjuvant chemotherapy for lung cancer. In: Ishigami J (ed) Recent advances in chemotherapy: proceedings of the 14th International Congress on Chemotherapy University of Tokyo Press, Tokyo, pp 155-157
9. 9. Gros P, Neriah YB, Croop JM, Housman DE (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323:728-731
10. 10. Chen CJ, Chin JE, Veda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdrl (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381-389
11. 11. Licht T, Pastan I, Gottesman M, Hermann F (1994) P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Ann Hematol 69:159-171
12. 12. Ling V (1995) P-glycoprotein; its role in drug resistance. Am J Med 99(Suppl):31S-34S
13. 13. World Health Organization (1982) Histological typing of lung tumors (WHO), edn 2. Am J Clin Pathol 77:123-136
14. 14. Grogan T, Dalton W, Rybski J, Spier C, Meltzer P, Richter L, Gleason M, Pindur J, Cline A, Scheper R, Tsuruo T, Salmon S (1990) Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Lab Invest 63:815-824
15. 15. Giorno R (1984) A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 2:161-166
16. 16. Dixon WJ (ed) (1988) BMDP statistical software. University of California Press, Berkeley, B34, pp 187-220
17. 17. Kaplan EL, Meier P (1965) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:203-224
18. 18. Petp R, Pike MC, Armitage P, Brestlow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39
19. 19. Cox DR (1972) Regression models and life tables. J R Stat Soc B 34:187-220
20. 20. Gottesman MM, Pastan I, Ambudkar SV (1996) P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6:610-617
21. 21. Bosch I, Croop MJ (1996) P-glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 1288:F37-F54
22. 22. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK16. Cancer
23. 23. Sugawara I (1990) Expression and functions of P-glycoprotein (mdrl gene product) in normal and malignant tissues. Acta Pathol Jpn 40:545-553
24. 24. Mizoguchi T, Yamada K, Furukawa T, Hidaka K, Hisatsugu T, Shimazu H, Tsuruo T, SumizawaT, Akiyama S (1990) Expression of the MDR1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 82:1679-1683
25. 25. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwaitkowski F, Plagne R, Chassagne J (1991) Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 83:111-116
26. 26. Scotto KW, Bielder JL, Melera PW (1986) Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 232:751-755
27. 27. Bell DR, Gerlach JH, Kartner N, Buick RN, Ling V (1985) Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol 3:311-315
28. 28. Rutledge M, Robey-Cafferty S, Silva E, Bruner J (1989) Monoclonal antibody (C219) detection of the multidrug resistant protein (P-glycoprotein) in routinely processed tissues: a study of 36 cases of ovarian carcinoma. Lab Invest 60:80A
29. 29. Chan HS, Haddad G, Thorner PS, Deboer G, Lin YP, Ondrusek N, Yeger H, Ling V (1991) P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325:1608-1614
30. 30. Dalton WS (1993) Drug resistance modulation in the laboratory and the clinic. Semin Oncol 20:64-69
31. 31. Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T, Kaye SB (1990) P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer 62:758-761
32. 32. Chen HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, Yeger H, Ling V (1991) P-glycoprotein expression as a predictor of the outcome of therapy for neuroblstoma. N Engl J Med 325:1608-1614